Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis.

Shuwei ZhouSiyu WangJian XiangZhongyu HanWeilang WangShuhang ZhangNoble Chibuike OparaShenghong JuYing CuiYuan-Cheng Wang

Published in: Abdominal radiology (New York) (2024)

ECA-MRI exhibited overall comparable diagnostic performance to EOB-MRI in assessing residual or recurrent HCC after LRT.

Keyphrases